US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jan 30, 2013 (14 years ago)

Brompheniramine/Pseudoephedrine Dm

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: Products are underdosed or have an incorrect dosage regime.

What was recalled

BROMPHENIRAMINE/PSEUDOEPHEDRINE DM, LIQUID, Antihistamine, Cough Suppressant, Decongestant, 16 fl oz. bottle, OTC, Manufactured for: Macoven Pharmaceuticals, Magnolia, TX 77354 NDC 44183-311-16

Recalling firm
TG United, Inc.
NDC code
44183-311-16
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-519-2013

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Ephedrine recalls

See all
Class II · Moderate risk Terminated

ePHEDrine in 0.9% sodium chloride

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc NDC 71286-6004-1 D-0003-2024
Class II · Moderate risk Terminated

ePHEDrine in 0.9% sodium chloride

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc NDC 71286-6004-1 D-1073-2023
Class II · Moderate risk Ongoing

Ephedrine Sulfate Injection

Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Akorn, Inc. D-0802-2023
Class III · Low risk Terminated

Allergy Relief D

Reason Failed dissolution specifications

Dr. Reddy's Laboratories, Inc. NDC 49032-273-20 D-0073-2023